09:00 – 09:35 Registration – tea/coffee and biscuits
09:35 – 09:45 Introduction by the Chairs: Dr Sefina Arif & Dr Colin Dayan, UK.
Prof. Paul Lehmann, CEO CTL & Case Western Reserve University, Germany.
10:10 – 10:35 Getting more information from Elispot assays
Dr John Wijdenes, Diaclone, France.
11.30 – 12:00 ELISPOT technology: clinical application for diagnosis and monitoring of infectious diseases
Dr Ajit Lalvani, Tuberculosis Immunology Group, Nuffield Department of Clinical Medicine, University of Oxford, John Radcliffe Hospital, UK
12:00 – 12:25 IFNgamma ELISpot assay: assessment in veterinary species or the evaluation of cell-mediated immunity after vaccination or infection
Mr Romain Paillot, Virology/Immunology, Animal Health Trust, Suffolk, UK
14:25 – 14:50 High sensitivity T cell ELISPOT assays: it's all about the background.
Dr Nilu Goonetilleke, The Weatherall Institute of Molecular Medicine University of Oxford, John Radcliffe Hospital, Oxford, UK.
14:50 – 15:20 Monitoring cytotoxic response by ELISPOT
15:50 – 16:15 The perforin ELISpot, optimisation and applications
Dr. Bartek Zuber, Mabtech AB, Sweden.
16:15 – 16:45 Clinical Application of the AELVIS ELISPOT Reader in Rheumatology and Endocrine Autoimmune Disorders
Prof. Dr. med. Heinfried H. Radeke, Dr.-Hans-Schleussner-Foundation Immune Pharmacology Clinic, J.W. Goethe University, Germany.
16:45 – 17:00 Chair’s summing up